Merix Pharmaceutical Corporation: Trial Finds Formula in RELEEV® 1 Day Cold Sore Highly Active Against Herpes
Botanically-derived formula found to heal cold sores in as little as one day in trial
Merix Pharmaceutical Corp., an industry leader in the treatment of cold sores and development of phyto-pharmaceutical technology, announces its proprietary botanical extract formula VIRACEA ® was found to be highly active against HSV-1 and HSV-2 in laboratory testing. In a double-blind, placebo controlled, clinical trial VIRACEA® was found to heal cold sores in as little as one day.
The patented Echinacea Extract formula is active in RELEEV® 1 Day Cold Sore Symptom Treatment. With FDA approved OTC antimicrobial antiseptic Benzalkonium Chloride also active, the treatment provides fast relief to those with painful cold sores. RELEEV® 1 Day Cold Sore Symptom Treatment is available in drugstores including Walgreens, CVS, and Rite Aid, and is now available in convenience stores, including 7-Eleven, in the United States.
RELEEV® eases the pain of cold sores, relieves other symptoms, and stops skin irritation after application. Those with cold sore symptoms using RELEEV® can expect fast and complete cold sore symptom and fever blister relief. Easily used at home or on the go, RELEEV® provides convenient relief for cold sore sufferers anywhere.
For more information about RELEEV® and to find it in a drugstore or convenience store near you, visit https://www.releev.com.
Established in 1998, Merix Pharmaceutical Corp. is a pioneering U.S. corporation with the primary mission of developing and marketing highly effective and safe medicines based upon its licensed bio-technology, Viracea.
Committed to easing the pain and suffering caused by infectious diseases while effectively treating the causative factor, and dedicated to ongoing research with emphasis on developing products, Merix utilizes its phyto-pharmaceutical technology in the area of antiviral and anti-infective medicine. It is believed, by leading healthcare professionals, that phyto-chemicals provide greater bio-availability with decreased cyto-toxicity, compared with other antiviral treatments.
CONTACT: Kristin Nugent
McNeil, Gray & Rice
617-367-0100, ext. 148